Navigation Links
Sanofi Pasteur Announces Results of U.S. Clinical Trials in Adults Following One Dose of Influenza A (H1N1) Vaccine
Date:10/1/2009

age and older, and in children 6 months of age through 9 years of age. Final data from these clinical trials, following a second dose of vaccine, will provide additional information to guide recommendations on the optimal dosage, number of doses and schedule. Influenza A (H1N1) 2009 Monovalent Vaccine was licensed by the U.S. Food and Drug Administration on September 15 as a monovalent strain change to Sanofi Pasteur's licensed seasonal influenza vaccine.

Sanofi Pasteur Clinical Trial Design

Sanofi Pasteur reported today on interim immunogenicity and safety results following one dose of the company's Influenza A (H1N1) 2009 Monovalent Vaccine in adults. Interim data from clinical trials in children, 21 days post-dose vaccination, will be available in early October. Both clinical trials are continuing to evaluate immunogenicity and safety following a second dose of vaccine.

The multi-center, randomized, placebo-controlled adult trial is being conducted in 849 adults divided into two age cohorts: 18 years through 64 years of age or 65 years of age and older. Study participants in each age cohort were randomized to four treatment groups. Three groups received a 0.5 mL injection of non-adjuvanted vaccine formulated to be either 7.5 mcg, 15 mcg or 30 mcg. The fourth group received the saline placebo control.

In the trial two doses of vaccine were administered, the second dose 21 days after the first. Immunogenicity was measured at day 21 prior to administration of the second dose and will be measured again 21 days after the second dose at day 42. An antibody titer of 1:40 or greater is generally considered a marker of seroprotection. A lower rise in antibody titers following vaccination may minimize the occurrence of disease and its consequences but is not considered seroprotective. Adverse events are being monitored throughout the clinical trial and will continue for 6 months after the second dose of vaccine.


'/>"/>
SOURCE Sanofi Pasteur
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
2. Sanofi Pasteur Receives FDA Approval of Meningococcal Vaccine for Children
3. Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine
4. Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for its Influenza Vaccine Global Stockpile
5. Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US
6. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
7. Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin
8. Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
9. Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study
10. Sanofi-aventis Stands Behind the Safety of Lantus(R)
11. Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014  Advanced Medical ... company engaged primarily in the development of brachytherapy ... applications, today announced that it has filed a ... and Drug Administration ("FDA") for marketing clearance for ... 513(f)(2) of the U.S. Food, Drug and Cosmetic ...
(Date:12/24/2014)... , Dec. 23, 2014  Lockton Dunning ... of Lockton Companies, announced the addition of Vice ... will join Lockton Dunning,s Pharmacy Consulting team, Excelsior ... of relevant industry experience to the position.  Most ... Market Sales at Diplomat Specialty Pharmacy, where she ...
(Date:12/24/2014)... CHAPEL HILL, N.C. , Dec. 23, 2014 /PRNewswire/ ... marketplace success. As the key link between the medical ... will grow even more in the coming years as ... relationships. According to research by benchmarking ... and MSLs can gain an important edge is by ...
Breaking Medicine Technology:Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3Kim Foerster Joins Lockton Companies 2Role of Medical Science Liaisons Evolving in Medical Device Sector 2
... The U.S. Food and Drug Administration today approved ... C. Victrelis is used for patients who still have ... previously treated with drug therapy for their hepatitis C ... for use in combination with peginterferon alfa and ribavirin. ...
... N.C., May 13, 2011 An organization,s internal and ... - roles for a company. Internal communications groups relay ... communications groups serve as the public face and voice ... evolved in the face of new technologies and marketplace ...
Cached Medicine Technology:FDA Approves Victrelis for Hepatitis C 2FDA Approves Victrelis for Hepatitis C 3Maximizing the Potential of Internal and External Communications Groups 2
(Date:12/25/2014)... Recently, Dylan Queen, a famous online ... its collection of discounted prom dresses, most of which ... spokesman of the company, the promotion is valid until ... to expand the UK market. , The prom dresses ... lengths, and styles: A-line strapless, empire strapless chiffon, one ...
(Date:12/25/2014)... sells many bamboo products and the business is famous ... announces big discounts on its bamboo mats , which ... the world’s leader in bamboo flooring. According to the ... 2015. , The bamboo mats are made from well-treated ... the bamboo strips for the mats are boiled and ...
(Date:12/25/2014)... 25, 2014 Recently, LunaDress.co.uk has updated its blog ... related accessories. Now, all of the models at LunaDress.co.uk come with ... groom lifts the wedding veil can turn out to be a ... A wedding veil can always bring surprise to a wedding. On ... how to choose veils for a big day . , ...
(Date:12/25/2014)... 25, 2014 (HealthDay News) -- Overeating is common during the ... in moderation, an expert says. "Don,t arrive at a ... if you know you,ll be attending a party, but deprivation ... lead dietitian at Northern Westchester Hospital in Mount Kisco, N.Y., ... eat healthy during the day and even to have a ...
(Date:12/25/2014)... tries its best to translate the experience of dress ... introduced its new collection of 2015 prom dresses, and ... prom outfits are guaranteed to contain the perfect designs ... designed for 2015. Anyone who wants to buy ... before Jan. 26, 2015, the deadline of the promotion. ...
Breaking Medicine News(10 mins):Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Angelweddingdress 2015 Prom Dresses Online Now 2
... informed individuals of recent conflicting news reports on the ongoing Baxter ... was not the cause of death among several patients, but the ... did cause death among patients. , ... Denver, CO ...
... kit is designed to answer questions often asked by denture ... fit better, give me more comfort and less pain?" The ... new always-soft Weber Denture Liner. All loose dentures (false ... this new (Patent Pending) invention. The Weber Denture Liner kit ...
... help docs spot those at risk for dementia, Parkinsons, researchers ... with a disorder that causes them to kick or cry ... or Parkinson,s disease, a new Canadian study suggests. , "It,s ... night," explained study author Dr. Ronald B. Postuma, of McGill ...
... but not help those with heart rhythm problems , , WEDNESDAY, ... reduce the chance of death from heart problems, but it ... analysis shows. , The conclusions are based on a Canadian ... 30,000 people. The study, by a team at the University ...
... stem cells may help link genes to human disorders, , , ... (ES) cells from rats have been derived by University of ... creation of far more effective animal models to study a ... development in stem cell research because we know that rats ...
... in the VIP Room of the Marriott Wardman Park ... of abstracts, the complete program of the Meetings, a ... January 5 through Wednesday, January 7, 7:30 a.m.-5:00 p.m., ... phone number is 202-745-2127. , The annual meetings ...
Cached Medicine News:Health News:LegalView Updates its Baxter Heparin Information Portal with Conflicting News Reports on the Possible Dangers 2Health News:LegalView Updates its Baxter Heparin Information Portal with Conflicting News Reports on the Possible Dangers 3Health News:LegalView Updates its Baxter Heparin Information Portal with Conflicting News Reports on the Possible Dangers 4Health News:New Product Makes Loose Dentures Fit Better 2Health News:New Product Makes Loose Dentures Fit Better 3Health News:Sleep Disorder Could Signal Neurological Disease 2Health News:Scientists Create New Means to Study Disease Origins 2Health News:Joint Mathematics Meetings in Washington, D.C. 2Health News:Joint Mathematics Meetings in Washington, D.C. 3Health News:Joint Mathematics Meetings in Washington, D.C. 4Health News:Joint Mathematics Meetings in Washington, D.C. 5Health News:Joint Mathematics Meetings in Washington, D.C. 6Health News:Joint Mathematics Meetings in Washington, D.C. 7Health News:Joint Mathematics Meetings in Washington, D.C. 8Health News:Joint Mathematics Meetings in Washington, D.C. 9Health News:Joint Mathematics Meetings in Washington, D.C. 10
Small size means convenient set up in any cath lab. ,System so versatile it can be mounted on I.V. pole or bedside, or bagged in sterile field....
... Used for vascular access. Hollow ... single wall puncture with two-part ... is visualized while maintaining thumb ... exits the hub of the ...
Used for placement of .035 inch (0.89 mm) or .038 inch (0.97 mm) diameter wire guides into the vascular system when a small 21 gage needle stick is desired....
Used to introduce balloon, electrode, closed or non-tapered end catheters and other devices for intervention....
Medicine Products: